NFE2L2 and chronic obstructive pulmonary disease: Indeed, activation of the NRF2 (nuclear erythroid-related factor 2) antioxidant pathway in COPD macrophages has been shown to improve bacterial clearance 99, suggesting that immunometabolic correction can provide clinical benefit.